(Reuters Health) - An approach to nursing home care that fosters interest and social interaction among patients and staff may reduce agitation and other neuropsychiatric symptoms in dementia sufferers and improve their quality of life, a recent trial suggests.
TOKYO/SEOUL (Reuters) - The World Trade Organization largely upheld a Japanese complaint against South Korean import bans and additional testing requirements imposed on Japanese seafood because of the 2011 Fukushima nuclear disaster.
(Reuters Health) - Black people with knee osteoarthritis may have a worse quality of life than white patients in part because they’re less likely to be offered knee replacement surgery or to get the procedure when it’s recommended, a U.S. study suggests.
(Reuters Health) - Learning to respond to your failures with kindness, or self-compassion, may help offset the negative effects of perfectionism at any age, according to a small study of Australian teens and adults.
TOKYO/GENEVA (Reuters) - A World Trade Organization ruling on Thursday largely upheld a Japanese complaint against South Korea's import bans and additional testing requirements imposed on Japanese seafood because of the 2011 Fukushima nuclear disaster.
(Reuters) - U.S. drugmaker Gilead Sciences Inc will use Sangamo Therapeutics Inc's gene-editing technology to develop cancer treatments in a deal potentially worth about $3 billion to Sangamo, the companies said on Thursday.
KAMPALA (Reuters) - Twenty-six refugees from the Democratic Republic of Congo have died in a camp in Uganda from acute diarrhea, and hundreds more cases have been registered, an official from the United Nations refugee agency UNHCR said on Thursday.
JOHANNESBURG (Reuters) - The death toll from an outbreak of the food-borne disease listeria in South Africa has more than doubled from previous numbers given in January to 172 deaths, the government said on Thursday.
COPENHAGEN/LONDON (Reuters) - The world's largest diabetes drugmaker, Novo Nordisk, on Thursday presented the first successful data from a large final-stage study of a pill it hopes will transform the diabetes market.
COPENHAGEN (Reuters) - The world's largest diabetes drugmaker Novo Nordisk on Thursday presented the first successful data from a final-stage study for a pill it hopes will transform the diabetes market.
AMSTERDAM (Reuters) - Dutch prosecutors on Thursday rejected a call by civil groups, hospitals and the city of Amsterdam to open a criminal case against major tobacco companies, saying the firms had adequately warned smokers of the health risks.
LONDON (Reuters) - A vast research study that sought to settle a long-standing debate about whether or not anti-depressant drugs really work has found they are indeed effective in relieving acute depression in adults.
(Reuters Health) - The amount of foods containing sugars or other carbohydrates that a woman eats has nothing to do with the likelihood she will start experiencing premenstrual syndrome (PMS), researchers say.
(Reuters) - Nearly 70 percent of children with potentially fatal acute Graft Versus Host Disease responded to treatment with an experimental stem cell therapy from Mesoblast Ltd, meeting the primary goal of a late-stage U.S. trial, the Australian company announced on Wednesday.
(Reuters Health) - The expensive anti-clotting drug Xarelto is no better than common aspirin when it comes to preventing painful and potentially-deadly clots in people who have just had total hip or total knee replacement surgery, according to a new Canadian study.
(Reuters) - AstraZeneca Plc said on Wednesday an advisory committee of the U.S. Centers for Disease Control and Prevention recommended the use of its FluMist Quadrivalent vaccine in the upcoming flu season, reversing its earlier position.
CARACAS (Reuters) - Venezuelans reported losing on average 11 kilograms (24 lbs) in body weight last year and almost 90 percent now live in poverty, according to a new university study on the impact of a devastating economic crisis and food shortages.